DIrect Effect of DPP-4 inhibitor on HbA1c levels and Renal Dysfunction

Trial Profile

DIrect Effect of DPP-4 inhibitor on HbA1c levels and Renal Dysfunction

Completed
Phase of Trial: Phase IV

Latest Information Update: 06 Jun 2017

At a glance

  • Drugs Teneligliptin (Primary) ; Sitagliptin
  • Indications Diabetic nephropathies; Type 2 diabetes mellitus
  • Focus Therapeutic Use
  • Most Recent Events

    • 01 Jun 2017 Status changed from active, no longer recruiting to completed.
    • 08 Sep 2014 Status changed from not yet recruiting to recruiting as per University Hospital Medical Information Network - Japan record.
    • 22 Oct 2013 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top